Table 4.
Effects of FXT on erythrocyte aggregation, blood and plasma viscosity in STZ diabetic rats (, n = 12).
| Group | Erythrocyte aggregation index | Whole blood viscosity (mPa/s) | Plasma viscosity (mPa/s) |
||
|---|---|---|---|---|---|
| γ = 200 (1/s) | γ = 60 (1/s) | γ = 1 (1/s) | γ = 60 (1/s) | ||
| Control | 0.85 ± 0.22 | 4.05 ± 0.34 | 4.64 ± 0.28 | 23.54 ± 2.23 | 0.97 ± 0.04 |
| STZ | 1.44 ± 0.69* | 4.41 ± 0.32* | 5.34 ± 0.37* | 27.74 ± 2.63* | 1.09 ± 0.18* |
| STZ + FXT 1.05 g/kg | 1.03 ± 0.19# | 4.31 ± 0.38 | 4.96 ± 0.37# | 25.36 ± 3.20# | 1.03 ± 0.06 |
| STZ + FXT 0.525 g/kg | 1.08 ± 0.25# | 4.24 ± 0.34 | 4.88 ± 0.30# | 25.28 ± 2.79# | 1.02 ± 0.08 |
The values are mean ± SD. *P < 0.05 versus control rats; # P < 0.05 versus diabetic rats.